Voltage-gated sodium channels (VGSCs) play a central role in the generation
and propagation of action potentials in neurons and other cells. VGSC modu
lators have their origins in empirical pharmacology and are being used as l
ocal anaesthetics, antiarrhythmics, analgesics and antiepileptics, and for
other disorders. However, the identification of a multigene family of VGSCs
, along with tools to study the different subtypes in pathophysiology, is n
ow providing a rational basis for selective intervention. Recent advances h
ave addressed the technical challenges of expressing and assaying these com
plex proteins, enabling the correlation of empirical pharmacology to subtyp
es and the screening of individual subtypes for novel inhibitors with incre
ased potency and selectivity.